A previous study has demonstrated the therapeutic efficacy of blocking the intermediate-conductance Ca2+-activated K+-channels (Kca3.1) for renal fibrosis, since fibroblasts overexpressed the channels under the pathologic condition [34]. The gene discussed is KCNN4; the disease is renal fibrosis.